Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0221 | 0.7996 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0414 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0134 | 0.4558 | 0.4558 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0028 | 0.0414 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0028 | 0.0414 | 1 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.6761 | 0.8455 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0414 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0134 | 0.4558 | 0.4606 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0414 | 0.0418 |
Brugia malayi | hypothetical protein | 0.004 | 0.0888 | 0.0888 |
Brugia malayi | Pax transcription factor protein 2 | 0.0269 | 0.9895 | 0.9895 |
Echinococcus multilocularis | geminin | 0.019 | 0.6761 | 0.6761 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0888 | 0.111 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.6761 | 0.8455 |
Echinococcus granulosus | geminin | 0.019 | 0.6761 | 0.6761 |
Schistosoma mansoni | jun-related protein | 0.0221 | 0.7996 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0134 | 0.4558 | 0.4606 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0028 | 0.0414 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0265 | 0.9707 | 0.981 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0272 | 1 | 1 |
Echinococcus granulosus | jun protein | 0.0272 | 1 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0269 | 0.9895 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0028 | 0.0414 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0272 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0018 | 0.0021 | 0.0021 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | jun protein | 0.0272 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.0888 | 0.0888 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0028 | 0.0414 | 1 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.0888 | 0.111 |
Brugia malayi | hypothetical protein | 0.0028 | 0.0414 | 0.0414 |
Onchocerca volvulus | 0.0269 | 0.9895 | 1 | |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0888 | 0.5 |
Brugia malayi | hypothetical protein | 0.0214 | 0.7703 | 0.7703 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.0888 | 0.0888 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0028 | 0.0414 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cytotoxicity (functional) | = 0.037 uM | In vitro cytotoxicity of compound was determined against CH1 (cisplatin resistant) cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.037 uM | In vitro cytotoxicity of compound was determined against CH1 (cisplatin resistant) cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.07 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.07 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.09 uM | In vitro cytotoxicity of compound was determined against CH1 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.09 uM | In vitro cytotoxicity of compound was determined against CH1 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against SKOV-3 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against SKOV-3 cell lines at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Cytotoxicity (functional) | = 0.105 uM | In vitro cytotoxicity of compound was determined against A2780 cell lines (cisplatin resistant) at 37 degree C after 96 hr | ChEMBL. | 10969983 |
Delta Tm (functional) | = 3.98 degrees C | Change in temperature (thermal denaturation) was determined from calf thymus DNA at 37 degree centigrade for 0 hours | ChEMBL. | 10969983 |
Delta Tm (functional) | = 4.61 degrees C | Change in temperature (thermal denaturation) was determined from calf thymus DNA at 37 degree centigrade for 4 hours | ChEMBL. | 10969983 |
Delta Tm (functional) | = 5.6 degrees C | Change in temperature (thermal denaturation) was determined from calf thymus DNA at 37 degree centigrade for 18 hours | ChEMBL. | 10969983 |
Resistance factor (functional) | = 0.4 | Resistance factor of compound was determined from cisplatin resistant CH1 cell lines to that of CH1 cell lines | ChEMBL. | 10969983 |
Resistance factor (functional) | = 1.5 | Resistance factor of compound was determined from cisplatin resistant A2780 cell lines to that of A2780 cell lines | ChEMBL. | 10969983 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.